Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Greenwald, 2005, The B7 family revisited., Annu Rev Immunol, 23, 515, 10.1146/annurev.immunol.23.021704.115611 Zhu, 2006, Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis [published erratum appears in J Immunol. 2006;176:5683]., J Immunol, 176, 3480, 10.4049/jimmunol.176.6.3480 Curiel, 2003, Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity., Nat Med, 9, 562, 10.1038/nm863 Shin, 2005, In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses., J Exp Med, 201, 1531, 10.1084/jem.20050072 Hirano, 2005, Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity., Cancer Res, 65, 1089, 10.1158/0008-5472.1089.65.3 Barber, 2006, Restoring function in exhausted CD8 T cells during chronic viral infection., Nature, 439, 682, 10.1038/nature04444 Okazaki, 2001, PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine., Proc Natl Acad Sci U S A, 98, 13866, 10.1073/pnas.231486598 Freeman, 2000, Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation., J Exp Med, 192, 1027, 10.1084/jem.192.7.1027 Brown, 2003, Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production., J Immunol, 170, 1257, 10.4049/jimmunol.170.3.1257 Nishimura, 1999, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor., Immunity, 11, 141, 10.1016/S1074-7613(00)80089-8 Nishimura, 2001, Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice., Science, 291, 319, 10.1126/science.291.5502.319 Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4., Science, 270, 985, 10.1126/science.270.5238.985 Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4., Immunity, 3, 541, 10.1016/1074-7613(95)90125-6 Thompson, 1997, The emerging role of CTLA-4 as an immune attenuator., Immunity, 7, 445, 10.1016/S1074-7613(00)80366-0 Chen, 2004, Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity., Nat Rev Immunol, 4, 336, 10.1038/nri1349 Iwai, 2003, PD-1 inhibits antiviral immunity at the effector phase in the liver., J Exp Med, 198, 39, 10.1084/jem.20022235 Dong, 2004, B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes., Immunity, 20, 327, 10.1016/S1074-7613(04)00050-0 Wang, 2005, Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes., Proc Natl Acad Sci U S A, 102, 11823, 10.1073/pnas.0505497102 Probst, 2005, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4., Nat Immunol, 6, 280, 10.1038/ni1165 Adler, 1998, CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells., J Exp Med, 187, 1555, 10.1084/jem.187.10.1555 Huang, 2004, Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigen., Eur J Immunol, 34, 1351, 10.1002/eji.200324734 Yang, 2004, Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance., Nat Immunol, 5, 508, 10.1038/ni1059 Redmond, 2003, Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC., J Immunol, 171, 6349, 10.4049/jimmunol.171.12.6349 Redmond, 2005, Peripheral tolerance of CD8 T lymphocytes., Immunity, 22, 275, 10.1016/j.immuni.2005.01.010 Heath, 2001, Cross-presentation, dendritic cells, tolerance and immunity., Annu Rev Immunol, 19, 47, 10.1146/annurev.immunol.19.1.47 Kurts, 1997, Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells., J Exp Med, 186, 239, 10.1084/jem.186.2.239 Shin, 2003, Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor., J Exp Med, 198, 31, 10.1084/jem.20030242 Adler, 2000, In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions., J Immunol, 164, 649, 10.4049/jimmunol.164.2.649 Morgan, 1996, CD8(+) T cell-mediated spontaneous diabetes in neonatal mice., J Immunol, 157, 978, 10.4049/jimmunol.157.3.978 Tseng, 2001, B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells., J Exp Med, 193, 839, 10.1084/jem.193.7.839 Kasahara, 2000, Inhibition of VEGF receptors causes lung cell apoptosis and emphysema., J Clin Invest, 106, 1311, 10.1172/JCI10259 Kumaraguru, 2004, Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo., J Immunol, 172, 3719, 10.4049/jimmunol.172.6.3719 Sheehy, 2001, A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis., J Immunol Methods, 249, 99, 10.1016/S0022-1759(00)00329-X